Experienced in Keratitis-Ichthyosis-Deafness Syndrome

Anna B. Fortina

Padova, IT 
Experienced in Keratitis-Ichthyosis-Deafness Syndrome
Padova, IT 
OverviewLocationsClinical Research

Overview

Anna Fortina practices in Padova, Italy. Ms. Fortina is rated as an Experienced expert by MediFind in the treatment of Keratitis-Ichthyosis-Deafness Syndrome. Her top areas of expertise are Mast Cell Activation Syndrome (MCAS), Systemic Mastocytosis, Atopic Dermatitis, and Contact Dermatitis.

Her clinical research consists of co-authoring 56 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Keratitis-Ichthyosis-Deafness Syndrome.

Gender
Female

Locations

Padova, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3 Multicenter, Double-Blind Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Adult Patients With Atopic Dermatitis
A Phase 3 Multicenter, Double-Blind Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Adult Patients With Atopic Dermatitis
Enrollment Status: Completed
Publish Date: September 03, 2024
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Combination With Topical Corticosteroids in Adult Patients With Moderate to Severe Atopic Dermatitis BREEZE-AD7
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Combination With Topical Corticosteroids in Adult Patients With Moderate to Severe Atopic Dermatitis BREEZE-AD7
Enrollment Status: Completed
Publish Date: August 11, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

56 Total Publications

Reactive Infectious Mucocutaneous Eruption (RIME) Associated With Rhinovirus and HHV-7 in a 14-Year-Old Boy.
Reactive Infectious Mucocutaneous Eruption (RIME) Associated With Rhinovirus and HHV-7 in a 14-Year-Old Boy.
Journal: Case reports in pediatrics
Published: September 16, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Fortina's expertise for a condition
ConditionClose
    View All 20 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile